Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Oct 24:8:237.
doi: 10.1186/1475-2875-8-237.

Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial

Victoria Nakibuuka  1 , Grace Ndeezi, Deborah Nakiboneka, Christopher M Ndugwa, James K Tumwine
Affiliations
Randomized Controlled Trial

Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial

Victoria Nakibuuka et al. Malar J. .

Abstract

Background: Malaria carries high case fatality among children with sickle cell anaemia. In Uganda, chloroquine is used for prophylaxis in these children despite unacceptably high levels of resistance. Intermittent presumptive treatment with sulphadoxine-pyrimethamine (SP) has shown great potential for reducing prevalence of malaria and anaemia among pregnant women and infants.

Objective: To compare the efficacy of monthly SP presumptive treatment, versus weekly chloroquine for malaria prophylaxis in children attending the Sickle Cell Clinic, Mulago Hospital.

Methods: Two hundred and forty two children with sickle cell anaemia were randomized to presumptive treatment with SP or weekly chloroquine for malaria prophylaxis. Active detection of malaria was made at each weekly visit to the clinic over one month. The primary outcome measure was the proportion of children with one malaria episode at one month follow-up. The secondary outcome measures included malaria-related admissions and adverse effects of the drugs.

Results: Ninety-three percent (114/122) of the children in the chloroquine group and 94% (113/120) in the SP group completed one month follow up. SP reduced prevalence of malaria by 50% compared to chloroquine [OR = 0.50, (95% CI 0.26-0.97)]; p = 0.042. Six percent (7/122) of the children receiving weekly chloroquine had malaria related admissions compared to 2.5% (3/120) on presumptive treatment with SP. No serious drug effects were reported in both treatment groups

Conclusion: Presumptive treatment with SP was more efficacious than weekly chloroquine in reducing prevalence of malaria in children with sickle cell anaemia. Continued use of chloroquine for malaria chemoprophylaxis in children with sickle cell anaemia in Uganda does not seem to be justified.

Trial registration: ClinicalTrials.gov NCT00124267.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trial profile.
See this image and copyright information in PMC

References

    1. Hendricks RG, Hendricks ED, Matthew DG. Disorders of the blood in paediatrics in the Tropics. Blackwell Scientific Publications, London; 1991. pp. 336–72.
    1. Paul D, Bernard J, Geerlings P, Bernard J, Brabin , Teunis A, Eggelete Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull World Health Organ. 2003;81:205–216. - PMC - PubMed
    1. Graham S, Ndugwa CM. Sickle cell disease in Uganda: a time for action. East Afr Med J. 2003;80:384–387. - PubMed
    1. World Health Organization . Prevalence of sickle cell disease. WHO, Geneva; 2005.
    1. Serjeant G. Mortality from Sickle cell Disease in Africa. BMJ. 2005;330:432–433. doi: 10.1136/bmj.330.7489.432. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data